The Canadian trial of carbohydrates in diabetes (CCD), a 1-y controlled trial of low-glycemic-index dietary carbohydrate in type 2 diabetes: no effect on glycated hemoglobin but reduction in C-reactive protein

被引:246
作者
Wolever, Thomas M. S. [1 ,3 ]
Gibbs, Alison L. [2 ]
Mehling, Christine [1 ]
Chiasson, Jean-Louis [4 ]
Connelly, Philip W. [3 ]
Josse, Robert G. [1 ,3 ]
Leiter, Lawrence A. [1 ,3 ]
Maheux, Pierre [5 ]
Rabasa-Lhoret, Remi [4 ]
Rodger, N. Wilson [6 ]
Ryan, Edmond A. [7 ]
机构
[1] Univ Toronto, Dept Nutr Sci, Toronto, ON M5S 3E2, Canada
[2] Univ Toronto, Dept Stat, Toronto, ON, Canada
[3] St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada
[4] Univ Montreal, Res Ctr Hotel Dieu Montreal, Montreal, PQ, Canada
[5] Univ Sherbrooke, Dept Med, Quebec City, PQ, Canada
[6] Univ Western Ontario, St Josephs Hlth Ctr, Dept Med, London, ON N6A 4V2, Canada
[7] Univ Alberta, Dept Med, Edmonton, AB, Canada
关键词
humans; randomized controlled clinical trial; diet; carbohydrate; diabetes; monounsaturated fat;
D O I
10.1093/ajcn/87.1.114
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: The optimal source and amount of dietary carbohydrate for managing type 2 diabetes (T2DM) are unknown. Objective: We aimed to compare the effects of altering the glycemic index or the amount of carbohydrate on glycated hemoglobin (HbA(1c)), plasma glucose, lipids, and C-reactive protein (CRP) in T2DM patients. Design: Subjects with T2DM managed by diet alone (n = 162) were randomly assigned to receive high-carbohydrate, high-glycemic-index (high-GI), high-carbohydrate, low-glycemic-index (low-GI), or low-carbohydrate, high-monounsaturated-fat (low-CHO) diets for 1 y. Results: The high-GI, low-GI, and low-CHO diets contained, respectively, 47%,52%, and 39% of energy as carbohydrate and 31%, 27%, and 40% of energy as fat; they had GIs of 63, 55, and 59, respectively. Body weight and HbA(1c) did not differ significantly between diets. Fasting glucose was higher (P = 0.041), but 2-h postload glucose was lower (P = 0.010) after 12 mo of the low-GI diet. With the low-GI diet, overall mean triacylglycerol was 12% higher and HDL cholesterol 4% lower than with the low-CHO diet (P < 0.05), but the difference in the ratio of total to HDL cholesterol disappeared by 6 mo (time x diet interaction, P = 0.044). Overall mean CRP with the low-GI diet, 1.95 mg/L, was 30% less than that with the high-GI diet, 2.75 mg/L (P = 0.0078); the concentration with the low-CHO diet, 2.35 mg/L, was intermediate. Conclusions: In subjects with T2DM managed by diet alone with optimal glycemic control, long-term HbA(1c) was not affected by altering the GI or the amount of dietary carbohydrate. Differences in total:HDL cholesterol among diets had disappeared by 6 mo. However, because of sustained reductions in postprandial glucose and CRP, a low-GI diet may be preferred for the dietary management of T2DM.
引用
收藏
页码:114 / 125
页数:12
相关论文
共 72 条
[1]  
[Anonymous], 1999, Can J Diabetes Care
[2]  
Borch-Johnsen K, 1999, LANCET, V354, P617
[3]   Five-week, low-glycemic index diet decreases total fat mass and improves plasma lipid profile in moderately overweight nondiabetic men [J].
Bouché, C ;
Rizkalla, SW ;
Luo, J ;
Vidal, H ;
Veronese, A ;
Pacher, N ;
Fouquet, C ;
Lang, V ;
Slama, G .
DIABETES CARE, 2002, 25 (05) :822-828
[4]   Low-glycemic index diets in the management of diabetes [J].
Brand-Miller, J ;
Hayne, S ;
Petocz, P ;
Colagiuri, S .
DIABETES CARE, 2003, 26 (08) :2261-2267
[5]   THE HIGH-MONOUNSATURATED FAT DIET AS A PRACTICAL ALTERNATIVE FOR NIDDM [J].
CAMPBELL, LV ;
MARMOT, PE ;
DYER, JA ;
BORKMAN, M ;
STORLIEN, LH .
DIABETES CARE, 1994, 17 (03) :177-182
[6]   THE EFFICACY OF ACARBOSE IN THE TREATMENT OF PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS - A MULTICENTER CONTROLLED CLINICAL-TRIAL [J].
CHIASSON, JL ;
JOSSE, RG ;
HUNT, JA ;
PALMASON, C ;
RODGER, NW ;
ROSS, SA ;
RYAN, EA ;
TAN, MH ;
WOLEVER, TMS .
ANNALS OF INTERNAL MEDICINE, 1994, 121 (12) :928-935
[7]  
Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO
[8]  
2-E
[9]  
Collins R, 2003, LANCET, V361, P2005
[10]  
CONNELLY PW, 1992, CAN MED ASSOC J, V146, P1977